Rafael Holdings, Inc.

RFL

US75062E1064

Real Estate Development & Operations

Real-time Estimate Cboe BZX Other stock markets 11:13:03 2024-04-30 am EDT			5-day change	1st Jan Change
1.515 ^USD	-11.92%		-8.19%	-14.21%

Mar. 13	Rafael Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2024	CI
2023	North American Morning Briefing : S&P 500 Eyes Record High as Rate Cut Hopes Underpin Sentiment	DJ

Cyclo Therapeutics, Inc. announced that it has received $5 million in funding from Rafael Holdings, Inc.

August 01, 2023

On August 2, 2023, Cyclo Therapeutics, Inc. closed the transaction.

Stocks mentioned in the article

	Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	Price	Change	5d. change	Capi.
	RAFAEL HOLDINGS, INC.	1.515 USD	-11.92%	-8.19%	42.29M
	CYCLO THERAPEUTICS, INC.	1.47 USD	0.00%	+19.83%	42.21M

Latest news about Rafael Holdings, Inc.

Rafael Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2024	Mar. 13	CI
North American Morning Briefing : S&P 500 Eyes Record High as Rate Cut Hopes Underpin Sentiment	Dec. 19	DJ
Tranche Update on Rafael Holdings, Inc.'s Equity Buyback Plan announced on April 4, 2023.	Dec. 14	CI
Rafael Holdings, Inc. Reports Earnings Results for the First Quarter Ended October 31, 2023	Dec. 14	CI
North American Morning Briefing : Traders Eye -2-	Dec. 12	DJ
Tranche Update on Rafael Holdings, Inc.'s Equity Buyback Plan announced on April 4, 2023.	23-10-30	CI
Rafael Holdings, Inc. Reports Earnings Results for the Full Year Ended July 31, 2023	23-10-30	CI
Rafael Holdings, Inc. Reports Earnings Results for the Fourth Quarter Ended July 31, 2023	23-10-30	CI
Earnings Flash (RFL) RAFAEL HOLDINGS Reports Q4 Revenue $68,000	23-10-30	MT
Earnings Flash (RFL) RAFAEL HOLDINGS Reports Q4 EPS $0.06	23-10-30	MT
Rafael Holdings, Inc. Announces Resignation of Rachel Jonas as Director	23-10-26	CI
Rafael Holdings, Inc. Announces Resignation of Boris Pasche as Director	23-08-09	CI
Cyclo Therapeutics, Inc. announced that it has received $5 million in funding from Rafael Holdings, Inc.	23-08-01	CI
Rafael Holdings, Inc.'s Equity Buyback Plan Extended till July 1, 2024.	23-06-30	CI
Rafael Holdings, Inc.'s Equity Buyback announced on April 4, 2023, has expired.	23-06-15	CI
Tranche Update on Rafael Holdings, Inc.'s Equity Buyback Plan announced on April 4, 2023.	23-06-13	CI
Rafael Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended April 30, 2023	23-06-13	CI
Cyclo Therapeutics Signs $5 Million Funding Deal with Rafael Holdings	23-06-05	MT
Cyclo Therapeutics, Inc. announced that it expects to receive $5 million in funding from Rafael Holdings, Inc.	23-05-31	CI
Cyclo Therapeutics, Inc. announced that it has received $2.1 million in funding from Rafael Holdings, Inc.	23-05-01	CI
Rafael Holdings, Inc. announces an Equity Buyback for $5 million worth of its shares.	23-04-04	CI
Rafael Holdings, Inc. authorizes a Buyback Plan.	23-04-03	CI
Rafael Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2023	23-03-14	CI
Rafael Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2023	23-03-14	CI
Protara Therapeutics Names Patrick Fabbio Financial Chief	23-01-30	MT

Rafael Holdings, Inc. is a holding company with interests in clinical and early-stage pharmaceutical companies. The Company's segments include healthcare and real estate. The Company's investments include Cornerstone Pharmaceuticals, Inc., which is a cancer metabolism-based therapeutics company; LipoMedix Pharmaceuticals Ltd., which is a clinical-stage pharmaceutical company; Barer Institute Inc., which is a preclinical cancer metabolism research operation; Cyclo Therapeutics Inc., which is a clinical-stage biotechnology company dedicated to developing medicines for patients and families living with diseases through its therapeutic asset like Trappsol and Cyclo; Day Three Labs, Inc., which offers pharmaceutical-grade technology like Unlokt, and Rafael Medical Devices, LLC, which is an orthopedic-focused medical device company developing instruments to advance minimally invasive surgeries. Its real estate segment comprises of a portion of a commercial building in Israel.

Sector

Real Estate Development & Operations

Calendar

2024-06-10 - Q3 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Real Estate Development & Operations

	1st Jan change	Capi.
RAFAEL HOLDINGS, INC.	-14.21%	42.29M
MITSUI FUDOSAN CO., LTD.	+39.94%	28.07B
SUN HUNG KAI PROPERTIES LIMITED	-13.85%	26.92B
DLF LIMITED	+22.78%	26.28B
CHINA RESOURCES LAND LIMITED	+1.61%	26.06B
MITSUBISHI ESTATE CO., LTD.	+49.67%	22.69B
CHINA OVERSEAS LAND & INVESTMENT LTD.	+5.96%	20.3B
EMAAR PROPERTIES	+3.66%	19.59B
SUMITOMO REALTY & DEVELOPMENT CO., LTD.	+30.95%	16.31B
POLY DEVELOPMENTS AND HOLDINGS GROUP CO., LTD.	-10.00%	15.21B

Other Real Estate Development & Operations

Rafael Holdings, Inc.

Equities

RFL

US75062E1064

Real Estate Development & Operations

Cyclo Therapeutics, Inc. announced that it has received $5 million in funding from Rafael Holdings, Inc.

Stocks mentioned in the article

Latest news about Rafael Holdings, Inc.

Chart Rafael Holdings, Inc.

Company Profile

Income Statement Evolution

Sector Other Real Estate Development & Operations